Commissioning of Calisseo’s Chinese FeedKind plant

Calysseo, a joint venture between Adisseo and Calysta, will initially produce 20,000 tonnes of protein per year from the plant in Chongqing, China. Once start-up operations are complete, the fermenter will become the largest protein production facility in the world.

FeedKind Protein offers aquaculture businesses a product that both helps preserve biodiversity while providing a high quality product that meets growing market needs.

The first deliveries, of FeedKind Aqua, will soon be made to customers, making it the first alternative fermented protein to address the sector on a large scale.

Jean-Marc Dublanc, CEO of Adisseo, said: “Food safety has been increasingly in the spotlight in recent months, but we are now entering a new era of sustainable food production. Calysseo brings to market a new way to manufacture high quality protein – and does so using a naturally occurring microbe that renders the resulting protein non-GMO, which is increasingly in demand in the supply chain.

“We have a long-standing commitment to improving the safety and sustainability of the food ingredients market and Calisseo fulfills an important part of this commitment. We will provide Chinese customers with a reliable, domestically available protein supply that meets their specific needs; produced in China for China.

“We look forward to working with our customers as they begin integrating this product into their supply chains.”

The microbial protein is produced by natural fermentation, which takes place inside a new large capacity U-loop reactor patented by Calysta. It responds to a growing need for a sustainable source of protein to meet the demands of a growing world population coupled with increased concerns over the preservation of biodiversity.

Because it needs no plant or animal matter and little water, it can be produced without impacting wild spaces.

The Chongqing facility will produce FeedKind Aqua for use in fish farming, allowing farmers to replace fishmeal and soybeans with a high-quality ingredient that does not require arable land or plant materials. Initially, production will be available for use in China, the largest aquaculture market in the world.

Alan Shaw, Co-Founder, CEO and President of Calysta, said in a press release, “Today is an incredible proud moment. We have spent the last 10 years perfecting our technology and it is exciting to have successfully implemented the world’s first industrial scale alternative protein fermenter. This is an important step as we aim to help make the world more food safe.

“Cellular agriculture, where proteins are grown in a controlled environment, is essential to helping the world meet its future food needs and we are proud to take the first steps in our journey to hyper-scaling this technology. with Adisseo, whom we look forward to working with for many years to come.

“This is an exciting time for Calysta as a whole, as we continue to work on bringing a host of additional protein ingredients to market for food and feed applications.”

FeedKind Aqua will meet a growing need for protein ingredients in the rapidly expanding global aquaculture market, which is experiencing strong growth and is expected to become the third largest source of animal protein, accounting for over 100 million tonnes of production.

The protein has been validated over several years following extensive testing on several popular aquaculture species including sea bass, sea bream and salmon. Thailand’s Kasetsart University, Thailand, recently discovered distinct benefits for shrimp, claiming that FeedKind promotes strong and healthy growth, while helping to activate the shrimp’s immune response to Vibrio, the causative agent of Shrimp Syndrome. early mortality (EMS). Since its discovery in 2009, EMS has wreaked havoc on the Asian aquaculture market, causing billions of dollars in losses.